AMCI vs ASML

AMCI's Piotroski F-Score of 5/9 indicates a stable but not strong financial health, with no Altman Z-Score available to assess bankruptcy risk. The company exhibits high profitability margins (23.64% profit margin, 45.62% operating margin) but suffers from severe revenue contraction (-52.60% YoY) and negative ROA (-14.92%), signaling deteriorating asset efficiency. Valuation multiples are extremely elevated (Price/Book: 21.31, Price/Sales: 26.12), suggesting the stock trades at a significant premium despite declining growth. Insider selling of $3.08M in the last 6 months further undermines confidence, and the lack of analyst coverage or target prices reflects market skepticism.

ASML exhibits strong financial health with a Piotroski F-Score of 4/9, indicating stable fundamentals despite not reaching the 'strong' threshold. The company's robust profitability metrics—especially a 50.46% ROE and 29.42% profit margin—underscore its operational excellence. While the current price of $1,345.69 trades at a premium to both the Graham Number ($193.99) and Intrinsic Value ($507.83), this is justified by exceptional growth prospects and dominant market positioning in semiconductor equipment. The recent earnings beat rate of 50% over the last four quarters and consistent positive surprises support a bullish outlook. The absence of an Altman Z-Score does not indicate distress risk, as the company maintains a low debt-to-equity ratio (0.24) and strong liquidity. Price trades at a 28.2% premium to fair value estimate ($1050.00), limiting near-term upside from a valuation perspective.